In vitro susceptibility of Ureaplasma urealyticum to rosaramicin.
Thirty-two clinical isolates of Ureaplasma urealyticum were inhibited by 0.036 mug of rosaramicin per ml, whereas 25 (78%) and 13 (41%) of the strains were inhibited by this concentration of minocycline and tetracycline, respectively. These results suggest that rosaramicin may be useful for the treatment of U. urealyticum infections.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D007933:Leucomycins / Q000494:pharmacology*; D008911:Minocycline / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014509:Ureaplasma / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D007933:Leucomycins; D013752:Tetracycline; D008911:Minocycline